Lv3
260 积分 2022-11-11 加入
Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial
4天前
已完结
Once-weekly semaglutide 7· 2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial
4天前
已关闭
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
3个月前
已完结
Animal models for development of anti-obesity drugs in the Age of GLP-1 Agents
5个月前
已完结
Amylin takes another shot at the obesity prize
10个月前
已完结
皖公网安备34019202002308
